wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27027093-ED1FDA12-940A-4B89-B47E-4B37436BBE95
Q27027093-ED1FDA12-940A-4B89-B47E-4B37436BBE95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27027093-ED1FDA12-940A-4B89-B47E-4B37436BBE95
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
P2860
Q27027093-ED1FDA12-940A-4B89-B47E-4B37436BBE95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27027093-ED1FDA12-940A-4B89-B47E-4B37436BBE95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eb66f07ce7b187c846937fa55a5ea6978e0e8ab0
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.